Overview
AI genomic drug development company with AI-designed biological assets
Funding
Amounts as reported; USD estimates shown only when they matchListed 1 funding record. Latest funding: $26M (Series B), Oct 6, 2026.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Oct 6, 2026 | $26M · Series B | AVP, Blast Club, Yaday Health | 1 source Source ↗ |
Evidence WhiteLab Genomics Raises $26M Series B to Accelerate AI-Driven Genomic MedicineOn October 6, 2026, per EU-Startups, Paris-based WhiteLab Genomics raised $26 million (€23.2M) in a Series B led by AVP, with new investors Yaday Health and Blast Club, to build AI-designed bio-assets for next-generation genomic medicines. Translated source brief, not a quotation. Check the original before citing. Sources · 1
| |||
Select ▸ on a row to see its source brief and links.
Valuation
Amounts as reported; USD estimates shown only when they matchListed 1 valuation record.
No chartable valuation estimates yet.
1 listed record lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Oct 6, 2026 | — · Series B | AVP, Blast Club, Yaday Health | 1 source Source ↗ |
Evidence WhiteLab Genomics Raises $26M Series B to Accelerate AI-Driven Genomic MedicineOn October 6, 2026, per EU-Startups, Paris-based WhiteLab Genomics raised $26 million (€23.2M) in a Series B led by AVP, with new investors Yaday Health and Blast Club, to build AI-designed bio-assets for next-generation genomic medicines. Translated source brief, not a quotation. Check the original before citing. Sources · 1
| |||
Select ▸ on a row to see its source brief and links.
Revenue
Amounts as reported; USD estimates shown only when they matchNo revenue records are listed yet.
No revenue rows to list.
Team, products & investors
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
AI基因组药物研发公司（AI设计的生物资产）